Systematic review / meta-analysis / 2019
Echinacea might have a preventative effect on respiratory tract infection incidence, but evidence does not show an effect on illness duration.
A systematic review and meta-analysis of randomised double-blind placebo-controlled trials evaluated echinacea preparations for upper respiratory tract infections. For prevention, echinacea was associated with a risk ratio of 0.78 (95% CI 0.68-0.88), while treatment showed a mean difference in duration of -0.45 days (95% CI 1.85-0.94), and safety analysis yielded a risk ratio of 1.09 (95% CI 0.95-1.25). The authors concluded echinacea might have a preventative effect on incidence, though whether it is clinically meaningful is debatable, and no evidence was found for an effect on duration. Findings are limited by clinical heterogeneity, risk of selective reporting, protocol deviations, and lack of author contact.
- Study type
- Systematic review and meta-analysis of RCTs
- Who was studied
- Otherwise healthy participants of any age and sex
- What was measured
- Prevention (incidence), duration, and safety of upper respiratory tract infections
THE PAPER
Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis.
David S, Cunningham R. Complement Ther Med, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.